قراءة
عرض

INFECTIVE ENDOCARDITIS

1


INFECTIVE ENDOCARDITIS: DEFINITION

Microbial infection of the endothelial surface of the heart

Characteristic lesion: VEGETATION

2


IE: DEFINITION:VEGETATIONS

Mass of platelets and fibrin, rich in bacteria, scanty inflammatory cells


Sites: heart valves, septal defect, chordae tendineae or mural endocardium

3


INFECTIVE ENDOCARDITIS: DEFINITION

Infection of arteriovenous shunts or PDA or coarctation of the aorta is called infective endarteritis, but clinically resembles IE
4


INFECTIVE ENDOCARDITIS: DEFINITION

Causative organism: bacteria, fungi, and rickettsiae

Most frequent organisms: streptococci, staphylococci, enterococci, and fastidious gram-negative coccobacilli

5






INFECTIVE ENDOCARDITIS: PATHOGENESIS
6


Vegatations on the mitral valve

Infective endocarditis


7

Vegetations on top of mitral stenosis

Infective endocarditis


8

Vegetations on a biologic valve

Infective endocarditis


9

IE: UNDERLYING HEART DISEASE

10




IE: UNDERLYING HEART DISEASE

Cardiac lesions with low or no pressure gradients are unlikely to be complicated by IE e.g. ASD
11


IE: MICRO-ORGANISMS

S. viridans
Enterococcus fecalis
Staphylococcus aureus
Coagulase negative Staphylococci
Gram-negative bacilli
Brucella
Rickettsia
Fungi

12






CLINICAL MANIFESTATIONS
13


IE: CLINICAL MANIFESTATIONS

14






Infective endocarditis


15


IE: PERIPHERAL MANIFESTATIONS

Splinter hemorrhage
Osler’s nodes: subcutaneous nodules, tender
Infective endocarditis



16

Osler’s nodes

Infective endocarditis


17

Dermal infarcts

Infective endocarditis


18

IE: EYE MANIFESTATIONS

Roth’s spots: on fundoscopy

Infective endocarditis


19

IE: EYE MANIFESTATIONS

Subconjunctival hemorrhage
20
Infective endocarditis


IE: PERIPHERAL MANIFESTATIONS: THE EYE

Petechiae: conjunctiva, buccal mucosa, limbs

21
Infective endocarditis

Janeway’s lesions: macular non-tender lesions on the palms and soles:

Evanesent: appear and disappear rapidly

22

CLINICAL MANIFESTATIONS

23

LOCAL DESTRUCTIVE EFFECTS

24






IE: SYSTEMIC EMBOLI
25


IE: NEUROLOGICAL MANIFESTATIONS

Headache
Confusion
Convulsions
Long tract signs & focal neurological deficit
Meningeal irritation
26


IE: RENAL MANIFESTATIONS

Glomerulonephritis
Focal renal infarcts: hematuria
Renal failure:
immune-complex deposition
Congestive heart failure
drug-induced
27




IE: CLINICAL SETUP

depending on the clinical presentation:
Acute IE:
Subacute IE (SBE)
Postoperative IE: following cardiac surgery
28


ACUTE IE

Caused by virulent organisms on top of normal heart:
Usually staphylococcus aureus
E.g. cannula infection, staphylococcal septicemia, drug abusers
29


ACUTE IE

30


ACUTE IE: CLINICAL MANIFESTATIONS
Severe febrile illness
Petechiae
Embolic events common
Rapid progression of cardiac and renal failure

31


SUBACUTE IE

Caused by infection with low-virulence organisms on top of pre-existing cardiac disease
Persistent fever, tiredness, weight loss, night sweats
32


PROSTHETIC VALVE ENDOCARDITIS

IE following cardiac surgery
Early postoperative IE:
infection is acquired at the time of surgery
High mortality: repeat surgery often required
Late postoperative IE:
Community-acquired infection
Complication rates lower than early form
33




IE: INVESTIGATIONS

Blood cultures
Echocardiography: transthoracic (TTE) and transesophageal (TEE)
Vegetations
Serial follow up
Valve damage
Abscess fromation

34


Vegatations on the aortic valve

Infective endocarditis


35

VEGETATIONS

Infective endocarditis



36


Infective endocarditis


37

38
Infective endocarditis



39
Infective endocarditis




Infective endocarditis


40

IE: INVESTIGATIONS

High ESR
Anemia of chronic disease
Neutrophil leucocytosis
CRP
Hematuria
Proteinuria
Low serum complement
Rheumatoid factor
41




IE: INVESTIGATIONS

ECG:
Heart block
Bundle branch block
arrhythmia
42


IE: TREATMENT

Combination antibiotic therapy according to culture & sensitivity
Empirical regimes pending the results of blood culture

43


IE: TREATMENT

Large doses
Given intravenously
Protracted duration of therapy:
usually 4 weeks
6 weeks in PVE


44


Combination AB therapy

Benzyl penicillin or ampicillin i.v
Plus gentamycin

For penicillin resistant or allergic: vancomycin infusion plus gentamycin

Oral rifampicin when staphylococcal infection suspected or confirmed
45


CARIAC SURGERY: INDICATIONS

Failure to respond to medical treatment
Heart failure due to valve insufficiency
Large vegetations
Abscess formation
46




PREVENTION OF IE

Susceptible patients: those with valvular or congenital heart disease
Good dental hygiene
47


PREVENTION OF IE

Avoidance of bacteremia
Antibiotic prophylaxis:
Dental manipulation
Genito-urinary tract catheterization or surgery

48


PROPHYLAXIS

For dental procedures:
Oral amoxicillin given 30 min before and 6 hours after the procedure
49








رفعت المحاضرة من قبل: Mubark Wilkins
المشاهدات: لقد قام 8 أعضاء و 645 زائراً بقراءة هذه المحاضرة








تسجيل دخول

أو
عبر الحساب الاعتيادي
الرجاء كتابة البريد الالكتروني بشكل صحيح
الرجاء كتابة كلمة المرور
لست عضواً في موقع محاضراتي؟
اضغط هنا للتسجيل